Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Xelstrym

Generic name: Dextroamphetamine

FDA application holder: Noven Pharms Inc

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Xelstrym?
Xelstrym is a brand name of Dextroamphetamine, a prescription medicine. The FDA NDC Directory lists 4 Xelstrym products in 4 strengths and forms.
Who makes Xelstrym?
Noven Pharms Inc holds the FDA application for Xelstrym (NDA215401, approved March 22, 2022).
Is there a generic or store brand of Xelstrym?
Other products of Dextroamphetamine are listed with the FDA, but none in exactly the same strength and form as a Xelstrym product.
What do pharmacies pay for Xelstrym?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 4 Xelstrym strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Xelstrym been recalled?
FDA enforcement reports list 1 recall of Xelstrym products; the newest started October 31, 2024. A recall usually concerns specific lots, not every product.

What Xelstrym is

Each Xelstrym product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Dextroamphetamine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
dextroamphetamine 13.5 mg
patch, extended release (transdermal)
Xelstrym None listed —
dextroamphetamine 18 mg
patch, extended release (transdermal)
Xelstrym None listed —
dextroamphetamine 4.5 mg
patch, extended release (transdermal)
Xelstrym None listed —
dextroamphetamine 9 mg
patch, extended release (transdermal)
Xelstrym None listed —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Dextroamphetamine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Xelstrym products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA215401Noven Pharms IncMarch 22, 20224

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Xelstrym, by strength and form
Strength and formGeneric or brandPharmacies pay
dextroamphetamine 13.5 mg
patch, extended release
Brand: Xelstrym $16.26 per patch
dextroamphetamine 18 mg
patch, extended release
Brand: Xelstrym $16.22 per patch
dextroamphetamine 4.5 mg
patch, extended release
Brand: Xelstrym $16.24 per patch
dextroamphetamine 9 mg
patch, extended release
Brand: Xelstrym $16.25 per patch

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Xelstrym

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Xelstrym products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. October 31, 2024 · Class II · Ongoing · D-0055-2025

    Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

    Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN — Noven Pharmaceuticals Inc

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers